Shopping Cart 0
Cart Subtotal
USD 0

Biotechnology in Germany

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 350

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 700

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 1050
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Biotechnology in Germany

Summary

Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Germany biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The German biotechnology industry had total revenues of USD 9.5bn in 2017, representing a compound annual growth rate (CAGR) of 6.8% between 2013 and 2017.

- The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of USD 4.7bn, equivalent to 49.7% of the industry's overall value.

- Germany's biotechnology industry is driven by its aging population, which is raising demand for medical drugs.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts

Reasons to buy

- What was the size of the Germany biotechnology market by value in 2017?

- What will be the size of the Germany biotechnology market in 2022?

- What factors are affecting the strength of competition in the Germany biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Germany's biotechnology market?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 15

New entrants 16

Threat of substitutes 18

Degree of rivalry 19

Leading Companies 20

Boehringer Ingelheim GmbH 20

Merck & Co., Inc. 23

MorphoSys AG 26

Macroeconomic Indicators 29

Country data 29

Methodology 31

Industry associations 32

Related MarketLine research 32

Appendix 33

About MarketLine 33


List Of Figure

List of Figures

Figure 1: Germany biotechnology industry value: USD billion, 2013-17

Figure 2: Germany biotechnology industry category segmentation: % share, by value, 2017

Figure 3: Germany biotechnology industry geography segmentation: % share, by value, 2017

Figure 4: Germany biotechnology industry value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the biotechnology industry in Germany, 2017

Figure 6: Drivers of buyer power in the biotechnology industry in Germany, 2017

Figure 7: Drivers of supplier power in the biotechnology industry in Germany, 2017

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Germany, 2017

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Germany, 2017

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Germany, 2017

Figure 11: Boehringer Ingelheim GmbH: revenues & profitability

Figure 12: Boehringer Ingelheim GmbH: assets & liabilities

Figure 13: Merck & Co., Inc.: revenues & profitability

Figure 14: Merck & Co., Inc.: assets & liabilities

Figure 15: MorphoSys AG: revenues & profitability

Figure 16: MorphoSys AG: assets & liabilities


List Of Table

List of Tables

Table 1: Germany biotechnology industry value: USD billion, 2013-17

Table 2: Germany biotechnology industry category segmentation: USD billion, 2017

Table 3: Germany biotechnology industry geography segmentation: USD billion, 2017

Table 4: Germany biotechnology industry value forecast: USD billion, 2017-22

Table 5: Boehringer Ingelheim GmbH: key facts

Table 6: Boehringer Ingelheim GmbH: key financials (USD )

Table 7: Boehringer Ingelheim GmbH: key financials (EUR)

Table 8: Boehringer Ingelheim GmbH: key financial ratios

Table 9: Merck & Co., Inc.: key facts

Table 10: Merck & Co., Inc.: key financials (USD )

Table 11: Merck & Co., Inc.: key financial ratios

Table 12: MorphoSys AG: key facts

Table 13: MorphoSys AG: key financials (USD )

Table 14: MorphoSys AG: key financials (EUR)

Table 15: MorphoSys AG: key financial ratios

Table 16: Germany size of population (million), 2013-17

Table 17: Germany gdp (constant 2005 prices, USD billion), 2013-17

Table 18: Germany gdp (current prices, USD billion), 2013-17

Table 19: Germany inflation, 2013-17

Table 20: Germany consumer price index (absolute), 2013-17

Table 21: Germany exchange rate, 2013-17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Biotechnology in Germany

Summary

Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Germany biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The German biotechnology industry had total revenues of USD 9.5bn in 2017, representing a compound annual growth rate (CAGR) of 6.8% between 2013 and 2017.

- The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of USD 4.7bn, equivalent to 49.7% of the industry's overall value.

- Germany's biotechnology industry is driven by its aging population, which is raising demand for medical drugs.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts

Reasons to buy

- What was the size of the Germany biotechnology market by value in 2017?

- What will be the size of the Germany biotechnology market in 2022?

- What factors are affecting the strength of competition in the Germany biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up Germany's biotechnology market?

READ MORE

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 15

New entrants 16

Threat of substitutes 18

Degree of rivalry 19

Leading Companies 20

Boehringer Ingelheim GmbH 20

Merck & Co., Inc. 23

MorphoSys AG 26

Macroeconomic Indicators 29

Country data 29

Methodology 31

Industry associations 32

Related MarketLine research 32

Appendix 33

About MarketLine 33


List Of Figure

List of Figures

Figure 1: Germany biotechnology industry value: USD billion, 2013-17

Figure 2: Germany biotechnology industry category segmentation: % share, by value, 2017

Figure 3: Germany biotechnology industry geography segmentation: % share, by value, 2017

Figure 4: Germany biotechnology industry value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the biotechnology industry in Germany, 2017

Figure 6: Drivers of buyer power in the biotechnology industry in Germany, 2017

Figure 7: Drivers of supplier power in the biotechnology industry in Germany, 2017

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Germany, 2017

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Germany, 2017

Figure 10: Drivers of degree of rivalry in the biotechnology industry in Germany, 2017

Figure 11: Boehringer Ingelheim GmbH: revenues & profitability

Figure 12: Boehringer Ingelheim GmbH: assets & liabilities

Figure 13: Merck & Co., Inc.: revenues & profitability

Figure 14: Merck & Co., Inc.: assets & liabilities

Figure 15: MorphoSys AG: revenues & profitability

Figure 16: MorphoSys AG: assets & liabilities


List Of Table

List of Tables

Table 1: Germany biotechnology industry value: USD billion, 2013-17

Table 2: Germany biotechnology industry category segmentation: USD billion, 2017

Table 3: Germany biotechnology industry geography segmentation: USD billion, 2017

Table 4: Germany biotechnology industry value forecast: USD billion, 2017-22

Table 5: Boehringer Ingelheim GmbH: key facts

Table 6: Boehringer Ingelheim GmbH: key financials (USD )

Table 7: Boehringer Ingelheim GmbH: key financials (EUR)

Table 8: Boehringer Ingelheim GmbH: key financial ratios

Table 9: Merck & Co., Inc.: key facts

Table 10: Merck & Co., Inc.: key financials (USD )

Table 11: Merck & Co., Inc.: key financial ratios

Table 12: MorphoSys AG: key facts

Table 13: MorphoSys AG: key financials (USD )

Table 14: MorphoSys AG: key financials (EUR)

Table 15: MorphoSys AG: key financial ratios

Table 16: Germany size of population (million), 2013-17

Table 17: Germany gdp (constant 2005 prices, USD billion), 2013-17

Table 18: Germany gdp (current prices, USD billion), 2013-17

Table 19: Germany inflation, 2013-17

Table 20: Germany consumer price index (absolute), 2013-17

Table 21: Germany exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com